During the past decade, Quality Clinical Research, Inc. conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 59 clinical trials were completed, i.e. on average, 103.5% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 36 clinical trials were completed. i.e. 124.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quality Clinical Research, Inc." #1 sponsor was "Pfizer" with 22 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 6 trials sponsored, "Allergan" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Ferring Pharmaceuticals" with 4 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quality Clinical Research, Inc." #1 collaborator was "AbCellera Biologics Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Quality Clinical Research, Inc." are "COVID-19" (6 trials), "Osteoarthritis" (6 trials), "Fibromyalgia" (5 trials), "Migraine" (5 trials) and "Chronic Idiopathic Constipation" (4 trials). Many other conditions were trialed in "Quality Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Quality Clinical Research, Inc." are "Drug" (79 trials), "Biological" (24 trials), "Other" (11 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "placebo" (11 trials), "Naproxen" (3 trials), "pregabalin" (3 trials) and "ABP-450" (2 trials). Other intervention names were less common.

The vast majority of trials in "Quality Clinical Research, Inc." are 91 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Quality Clinical Research, Inc.". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 79 completed trials in Quality Clinical Research, Inc., 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Quality Clinical Research, Inc., 3 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".